NeuroBo Pharmaceuticals Inc. (NRBO) Fundamentals

NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases, has a current portfolio of four drug candidates. The company's acquired ANA001 candidate is a proprietary oral niclosamide formulation in development as a treatment for patients with moderate to severe COVID-19. ANA001 is being studied in a 60-subject Phase 2/3 clinical trial conducted at up to 20 clinical sites in the USA. The company's NB-01 candidate has been shown in a Phase 2 study to significantly reduce pain symptoms associated with painful diabetic neuropathy (PDN), with a superior safety profile when compared to currently available treatments.
SHARE INFORMATION
Market Cap$ 8,974,869
Shares Outstanding6,503,528
Float6,204,528
Percent Float95.4%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -19.78
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions38
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months13,180
Institutional Holdings Percent1.1%
Institutional Sold Previous 3 Months310,145
Insider Holdings Date2022-11-30
Insider Bought Previous 3 Months-
Insider Holdings Percent94.0
Insider Sold Previous 3 Months-
Insider Shares Owned3,791,617
TRADING INFO
52 Week High$ 63.85
52 Week Low$ 1.13
52 Week High Change$ -96.83
21 Day Moving Average$ 1.4124
21 Day Extended Moving Average$ 2.3833
50 Day Moving Average$ 6.5369
50 Day Extended Moving Average$ 5.5393
200 Day Moving Average$ 14.7623
200 Day Extended Moving Average$ 19.5214
10 Day Average Volume5,808,704
20 Day Average Volume6,634,792
30 Day Average Volume5,226,435
50 Day Average Volume3,178,917
Alpha-0.078332
Beta-0.2381
Standard Deviation0.278441
R20.002070
7 Day Price Change$ -0.07
7 Day Percent Change-4.83%
21 Day Price Change$ 0.01
21 Day Percent Change0.73%
30 Day Price Change$ -0.78
30 Day Percent Change-36.11%
Month to Date Price Change$ -0.07
Month to Date Percent Change-4.83%
Quarter to Date Price Change$ -12.31
Quarter to Date Percent Change-89.92%
180 Day Price Change$ -12.85
180 Day Percent Change-90.3%
200 Day Price Change$ -13.82
200 Day Percent Change-90.92%
Year to Date Price Change$ -35.22
Year to Date Percent Change-96.23%

NeuroBo Pharmaceuticals Inc. (NRBO) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.60
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio4.70
Leverage Ratio1.20
Quick Ratio3.90
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.10
Enterprise Value$ 2,879,009
Price to Sales0.00
Price to Free Cash-0.70
PE High Last 5 Years-3.50
Price To Book1.60
Price To Cash Flow0.00
PE Low Last 5 Years-3.80
Price to Tangible Book1.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-177.42
Return on Equity-229.94
Return on Capital-228.97

NeuroBo Pharmaceuticals Inc. (NRBO) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorBDO USA, LLP
CEOBen Gil Price
Emplyoees5
Last AuditUE
CIK0001638287
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address200 Berkeley Street
Office 19th Floor
Boston, MA 2116
Websitehttps://www.neurobopharma.com
Facsimile-
Telephone+1 857 702-9600
Emailinfo@neurobopharma.com
Your Recent History
NASDAQ
NRBO
NeuroBo Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221209 00:18:12